1 ottobre 2025 – ZEISS Vision Care has entered into a definitive agreement to acquire a 10% stake in Ocumeda AG at a total company valuation of EUR 100m from Fielmann Group with the intention to extend the investment up to a 25% stake. Ocumeda is Europe’s leading tele-ophthalmology platform connecting about 300,000 active patients and 700 optical retail stores with ophthalmologists and the medical community. ZEISS Vision Care and Fielmann Group plan to expand the open teleophthalmology platform across Europe.

Walder Wyss advised Fielmann Group and Ocumeda in this transaction. The team was led, together with Dr. Fabian Walla, Fielmann’s Group General Counsel, by Robert von Rosen (Partner, Corporate/M&A) and further included Monique Sturny (Partner, Competition), Marius Breier (Partner, Tax), Christoph Burkhardt (Senior Associate, Corporate/M&A), Vangelis Kalaitzidakis (Managing Associate, Tax), Oerjan Wickart (Associate, Corporate/M&A), Johannes Stamm (Associate, Competition) and Lorenzo Petrone (Associate, Corporate/M&A).